Philadelphia, 7-8 March 2011: Patient Adherence Summit
Healthcare Engagement Strategy e-journal is proud to have been selected as a media partner for the Patient Adherence Summit, which takes place March 7-8, 2011 in Philadelphia, USA.
Here’s what the organizers are saying about the event:
Medication non-adherence is an enormous problem in health care today, with an estimated half of all patients in the United States not taking their medications as prescribed. A lack of compliance and persistency contributes to preventable negative health outcomes, billions of dollars in wasted medical spending, and lost revenue for manufacturers. Many factors contribute to non-adherence, and ultimately, companies need to address individual patient concerns and understanding in order to influence adherent behavior. While there is no magic bullet, pharmaceutical, biotech and medical device companies, through effective disease state awareness campaigns, patient support programs, and product marketing, are faced with a tremendous opportunity to inform and drive positive patient behavior.
ExL Pharma’s Medication Adherence Summit is not the “same old adherence conference,” as it features exciting new topics and speakers. This event is designed to give attendees cutting edge information for implementing innovative product adherence strategies in a time of mounting competition with “me-too” products and generics. The expert speaking faculty provides concrete strategies for streamlining marketing spend, forming effective stakeholder partnerships, and ultimately overcoming barriers to adherence for different consumer groups and disease classes. This is a must-attend event for commercial teams and individuals in patient advocacy and support. We look forward to greeting you in Philadelphia in March!
Rave Reviews from Previous ExL Events:
“This was a very valuable experience for me. I look forward to participating next year.” – Vice President, Managed Markets, Daiichi Sankyo
“Great event, quality speakers and wonderful interactions.” – Associate Director, Corporate Communications, Genzyme
“Great program; very informative. The topics and speakers are dead on.” – Senior Director, US Corporate Compliance, Sanofi-Aventis
“Excellent conference. The sessions were very informative and this is such an important event.” – Senior Manager, Bristol-Myers Squibb
For more information about the Patient Adherence Summit, click here.